Advanced Solid Malignancies Terminated Phase 1 Trials for AZD-4547 (DB12247)

Also known as: Advanced Solid Malignancy

IndicationStatusPhase
DBCOND0034803 (Advanced Solid Malignancies)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00979134Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced TumoursTreatment